Statement: the primary trial participants are administered Avastin, Bevacizumab and radiotherapy as part of the intervention
Primary_evidence: INTERVENTION 1:    Avastin (Bevacizumab) Plus Hormone   All patients received Avastin (Bevacizumab) 15 mg/kg IV every three weeks as well as continuing with hormonal therapy they previously were taking.